Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao Min Wan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|July 6, 2007
Cost-utility analysis in China: differences and difficulties compared with developed countriesLiu Bao Peng, Chong Qing Tan, Xiao Min Wan, et al.
Cancer|March 17, 2017
Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectivesXiao Min Wan, Liu Bao Peng, Jin An Ma, et al.
The Journal of Organic Chemistry|March 14, 2018
NNN Pincer Ru(II)-Complex-Catalyzed α-Alkylation of Ketones with AlcoholsXiao-Niu Cao, Xiao-Min Wan, Fa-Liu Yang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|July 6, 2007
Cost-utility analysis in China: differences and difficulties compared with developed countriesLiu Bao Peng, Chong Qing Tan, Xiao Min Wan, et al.
Cancer|March 17, 2017
Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectivesXiao Min Wan, Liu Bao Peng, Jin An Ma, et al.
The Journal of Organic Chemistry|March 14, 2018
NNN Pincer Ru(II)-Complex-Catalyzed α-Alkylation of Ketones with AlcoholsXiao-Niu Cao, Xiao-Min Wan, Fa-Liu Yang, et al.
Pageof 1